Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
about
Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia.Personal lifestyle as a resource for work engagement.Elevated DNA Oxidation and DNA Repair Enzyme Expression in Brain White Matter in Major Depressive Disorder.Cytokines in bipolar disorder: paving the way for neuroprogression.Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.Psychoneuroimmunology or immunopsychiatry?Beyond serotonin: newer antidepressants in the future.The promise of biological markers for treatment response in first-episode psychosis: a systematic review.Attempted infanticide and suicide inaugurating catatonia associated with Hashimoto's encephalopathy: a case reportInflammation and depression: combined use of selective serotonin reuptake inhibitors and NSAIDs or paracetamol and psychiatric outcomes.Investigational dopamine antagonists for the treatment of schizophrenia.Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.Cyclooxygenase-2 inhibition reduces stress-induced affective pathology.Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophreniaMinocycline and celecoxib as adjunctive treatments for bipolar depression: a study protocol for a multicenter factorial design randomized controlled trial.Ethical Implications of the Mild Encephalitis Hypothesis of Schizophrenia.Emerging drugs for schizophrenia: an update.Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset.Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.The renin-angiotensin system: a possible new target for depression.Chronic peripheral inflammation, hippocampal neurogenesis, and behavior.Is it time for immunopsychiatry in psychotic disorders?Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression.Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System."I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and Depression.Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels.Reconceptualization of translocator protein as a biomarker of neuroinflammation in psychiatry.Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.Therapeutic strategies for treatment of inflammation-related depression.Targeting the Immune System with Pharmacotherapy in Schizophrenia.A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.Neuroscience, mental health and the immune system: overcoming the brain-mind-body trichotomy.A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report.Mania induced by adalimumab in a patient with ankylosing spondylitis.Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review
P2860
Q30383068-E798BAC0-2240-4C98-BA07-A859D144E9EAQ33554719-B91A2437-BAB7-477D-9D3F-DD63F78549E6Q33623455-0E0C7A27-B766-4814-B3F0-895A335A4490Q34233926-98CAA791-64FD-4141-9202-344739D16619Q34432085-3848FED0-7FA8-481B-8B6D-8FC884898162Q34493614-9BB45D4E-4BA9-4A25-9EE3-0A532A32BAD0Q34557706-04BDE92E-0FF1-46B5-8D81-87EB7A77B02EQ35369988-9FF94E03-12B6-4813-A1CB-892E91ED4C88Q35898377-1BBA12FF-93BD-4800-A062-2F1A13374174Q36023793-A501D43A-90B1-4634-8765-DAE63992BB33Q36356306-6CC6C021-C4B0-4076-92A3-3597AF059982Q36526417-6B0D3D31-D23D-4B6A-871E-FD43252E6C59Q36888657-CEB9E423-6693-4343-849E-37AD06CC49B8Q37310533-08301300-09D1-4DF0-B60D-0F4357D8C582Q37347570-816915FB-D0B3-41F6-A642-44C94C90318BQ37530855-F63714FA-BEEC-4B10-8637-C9BCB074FFFCQ37694507-F6B754E5-DF5E-46D4-BB1B-C052B26C2C5BQ38252404-4B6E0A44-8BCD-4AB2-A580-2407AB9B11CAQ38392954-F5C06625-F74B-4488-8838-64615CD19118Q38454097-045CD7FC-0BDD-4D17-9209-86D7A34B4E04Q38651269-671717BF-1128-4CAF-B8C4-5F30A7B63685Q38709043-04C853C8-D07E-4141-ACAD-790781906C7AQ38779149-0321539F-D641-4891-9DE7-7EAF4384A26AQ38901511-C3C57E4F-35F8-434A-A72E-27926F0F6201Q39152857-9C9A9943-71FD-4FA1-B36D-1DAF9AE77B97Q40063542-60FE74DB-1C48-4BD9-A5F9-D5949DAC6573Q40826810-D8511C93-A186-4F74-9D63-AA387DD26673Q47331971-156B34A6-9C71-4EFA-92AD-33265002E42FQ47582903-8ECB8923-6F76-4F89-B8B7-EB4470B921B4Q47785792-69B8F46B-674F-41FF-BF40-F787804DAEACQ47837511-E0A7417C-CD36-4B29-B863-947382BC4473Q47861374-8A2E5B4F-87E0-427E-B876-EA3187B5BEC5Q48063579-881A8803-6960-4B49-AD1B-181EE9AC9ED2Q48071831-062C0C92-DF3C-4FA7-94BF-41B0712E79CFQ48266735-71AC89CE-9F42-4809-8AED-A46AD9CE8ED1Q53817869-F584893B-0C4F-4816-B284-958DA2CE55F7Q57700286-BF290038-719E-41B3-B1DA-5C5AB1A2316FQ58712660-18B617E3-ECC3-49EF-AB6A-29F1B578FA43
P2860
Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Effectiveness and tolerance of ...... systematic qualitative review.
@ast
Effectiveness and tolerance of ...... systematic qualitative review.
@en
Effectiveness and tolerance of ...... systematic qualitative review.
@nl
type
label
Effectiveness and tolerance of ...... systematic qualitative review.
@ast
Effectiveness and tolerance of ...... systematic qualitative review.
@en
Effectiveness and tolerance of ...... systematic qualitative review.
@nl
prefLabel
Effectiveness and tolerance of ...... systematic qualitative review.
@ast
Effectiveness and tolerance of ...... systematic qualitative review.
@en
Effectiveness and tolerance of ...... systematic qualitative review.
@nl
P2093
P2860
P50
P356
P1476
Effectiveness and tolerance of ...... systematic qualitative review.
@en
P2093
E Marlinge
N Drancourt
W Boukouaci
P2860
P304
P356
10.1111/ACPS.12211
P407
P577
2013-11-11T00:00:00Z